The discordant FGFR3 mutation status as suggested by the above studies where some tumors harboring FGFR3 mutation early in the non-invasive stage convert to wild type FGFR3 during tumor progression might reflect the importance of this pathway at an early stage of carcinogenesis. This evidence concerns the gene FGFR3 and neoplasm.